DK306487D0 - Farmaceutisk kapsel med langvarig/hurtig frigoerelse til oral indgivelse af nitrofurantoin og fremgangsmaade til fremstilling af samme - Google Patents

Farmaceutisk kapsel med langvarig/hurtig frigoerelse til oral indgivelse af nitrofurantoin og fremgangsmaade til fremstilling af samme

Info

Publication number
DK306487D0
DK306487D0 DK306487A DK306487A DK306487D0 DK 306487 D0 DK306487 D0 DK 306487D0 DK 306487 A DK306487 A DK 306487A DK 306487 A DK306487 A DK 306487A DK 306487 D0 DK306487 D0 DK 306487D0
Authority
DK
Denmark
Prior art keywords
nitrofurantoin
procedure
term
long
oral administration
Prior art date
Application number
DK306487A
Other languages
English (en)
Other versions
DK173432B1 (da
DK306487A (da
Inventor
Vikram Suresh Patel
Harry Leslie Welles
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of DK306487D0 publication Critical patent/DK306487D0/da
Publication of DK306487A publication Critical patent/DK306487A/da
Application granted granted Critical
Publication of DK173432B1 publication Critical patent/DK173432B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198703064A 1986-06-16 1987-06-16 Farmaceutisk kapsel med både hurtig og langvarig frigørelse til oral indgivelse af nitrofurantoin og fremgangsmåde til frem DK173432B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/874,943 US4772473A (en) 1986-06-16 1986-06-16 Nitrofurantoin dosage form
US87494386 1986-06-16

Publications (3)

Publication Number Publication Date
DK306487D0 true DK306487D0 (da) 1987-06-16
DK306487A DK306487A (da) 1987-12-17
DK173432B1 DK173432B1 (da) 2000-10-23

Family

ID=25364916

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703064A DK173432B1 (da) 1986-06-16 1987-06-16 Farmaceutisk kapsel med både hurtig og langvarig frigørelse til oral indgivelse af nitrofurantoin og fremgangsmåde til frem

Country Status (13)

Country Link
US (1) US4772473A (da)
EP (1) EP0250023B1 (da)
JP (1) JP2509226B2 (da)
AT (1) AT398166B (da)
AU (1) AU592731B2 (da)
CA (1) CA1288050C (da)
DE (1) DE3772113D1 (da)
DK (1) DK173432B1 (da)
IE (1) IE60661B1 (da)
IL (1) IL82807A (da)
NZ (1) NZ220695A (da)
PH (1) PH22843A (da)
ZA (1) ZA874316B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917892A (en) * 1988-06-28 1990-04-17 Temple University Encapsulated topical delivery system
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
US5360402A (en) * 1990-01-10 1994-11-01 Rochester Medical Corporation Hand-actuated retention catheter
US5269770A (en) * 1990-01-10 1993-12-14 Rochester Medical Corporation Microcidal agent releasing catheter with balloon
US5670111A (en) * 1990-01-10 1997-09-23 Rochester Medical Corporation Method of shaping structures with an overcoat layer including female urinary catheter
US5971954A (en) * 1990-01-10 1999-10-26 Rochester Medical Corporation Method of making catheter
US5261896A (en) * 1990-01-10 1993-11-16 Rochester Medical Corporation Sustained release bactericidal cannula
US6626888B1 (en) 1990-01-10 2003-09-30 Rochester Medical Corporation Method of shaping structures with an overcoat layer including female urinary catheter
CN1195550C (zh) * 1998-12-28 2005-04-06 大正制药株式会社 外用剂
MXPA02005562A (es) * 1999-12-06 2004-09-10 Penwest Pharmaceuticals Co Superdesintegrante farmaceutico.
PL370793A1 (en) * 2001-07-04 2005-05-30 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
PE20040134A1 (es) * 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
US20060002997A1 (en) * 2002-08-23 2006-01-05 Puneet Shamar Nitrofurantoin controlled release dosage form
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
NZ553645A (en) 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
NZ553561A (en) * 2004-08-13 2010-12-24 Boehringer Ingelheim Int Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
US8603200B2 (en) * 2009-06-22 2013-12-10 Afton Chemical Corporation Compositions comprising combustion improvers and methods of use thereof
CN102000041A (zh) * 2010-11-19 2011-04-06 合肥合源药业有限公司 含有速释和缓释两种成分的呋喃坦啶胶囊及其制备方法
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
KR102462510B1 (ko) 2014-08-26 2022-11-01 씨. 알. 바드, 인크. 요로 카테터
JP7350722B2 (ja) 2017-09-19 2023-09-26 シー・アール・バード・インコーポレーテッド 尿カテーテルブリッジ装置、そのシステムおよび方法
EP4285895A1 (en) * 2022-06-03 2023-12-06 Adalvo Limited Nitrofurantoin oral dosage form

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171628C (nl) * 1950-05-29 Inst Francais Du Petrole Inrichting voor het uitzenden van akoestische golven in een vloeibaar milieu.
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4152444A (en) * 1972-04-19 1979-05-01 Ciba-Geigy Corporation Pharmaceutical compound preparations with bactericidal action
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
CA1288050C (en) 1991-08-27
DK173432B1 (da) 2000-10-23
IE871585L (en) 1987-12-16
ATA151687A (de) 1994-02-15
EP0250023A1 (en) 1987-12-23
ZA874316B (en) 1988-08-31
EP0250023B1 (en) 1991-08-14
IL82807A (en) 1991-12-12
NZ220695A (en) 1990-08-28
AT398166B (de) 1994-10-25
AU7421187A (en) 1987-12-17
JP2509226B2 (ja) 1996-06-19
IE60661B1 (en) 1994-08-10
IL82807A0 (en) 1987-12-20
DK306487A (da) 1987-12-17
PH22843A (en) 1989-01-19
DE3772113D1 (de) 1991-09-19
US4772473A (en) 1988-09-20
AU592731B2 (en) 1990-01-18
JPS63258420A (ja) 1988-10-25

Similar Documents

Publication Publication Date Title
DK306487A (da) Farmaceutisk kapsel med langvarig/hurtig frigoerelse til oral indgivelse af nitrofurantoin og fremgangsmaade til fremstilling af samme
DK306587A (da) Farmaceutisk kapsel med langvarig frigoerelse til oral indgivelse og fremgangsmaade til fremstilling af samme
DK495585D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme
DK287687A (da) Nyt laegemiddelpraeparat med kontrolleret frigivelse af den virksomme forbindelse, fremgangsmaade til fremstilling deraf og anvendelse af det nye praeparat
DK52787A (da) Laegemiddelpraeparat med protraheret virkning og fremgangsmaade til fremstilling heraf
NO871243D0 (no) Farmasoeytisk preparat med langvarig frigjoering og fremgangsmaate for dets fremstilling.
DK165830C (da) Selvbaerende keramisk komposit og fremgangsmaade til fremstilling deraf
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK153387D0 (da) Fremgangsmaade til fremstilling af laegemiddel-adsorbater
DK52887A (da) Laegemiddelpraeparat med protraheret frigoerelse og fremgangsmaade til fremstilling heraf
DK364987A (da) Laegemiddelholdige fibre med kontrolleret frigoerelse og fremgangsmaade til fremstilling heraf
DK529885A (da) Farmaceutiske kapsler med langvarig frigivelse
NO873993D0 (no) Fremgangsmaate for fremstilling av fluorid- og calsiumpreparat med langvarig frigivelse.
DK408786A (da) Fremgangsmaade til fremstilling af vitaminforstadier og vitaminer
DK16187D0 (da) Farmaceutisk sammensaetning med langvarig frigoerelse og fremgangsmaade til fremstilling af samme
DK94686D0 (da) Nye oxadiazolylimidazobenzodiazepinderivater og fremgangsmaader til fremstilling af samme
DK165965C (da) Farmaceutisk praeparat med antihypertensiv virkning og fremgangsmaade til fremstilling heraf
DK424987D0 (da) Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling
DK525187A (da) Imidazooe4,5-baapyridinon-2-derivater, fremgangsmaade til fremstilling af og laegemidler indeholdende saadanne derivater
DK152087A (da) Indretning og fremgangsmaade til indstilling af tandlaegestol
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK173287A (da) Perhydrothiazepin- og perhydroazepinderivater og fremgangsmaade til fremstilling deraf
DK617187A (da) Fremgangsmaade til fremstilling af tabeletter med clovoxamin-fumarat og de saaledes fremstillede tabletter
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK436887D0 (da) Fremgangsmaade til fremstilling af triazol-tetrahydrofuran-derivater og mellemprodukter til anvendelse herved

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired